Inflammatory myofibroblastic tumour of the bladder may express anaplastic lymphoma kinase by translocation‐dependent and translocation‐independent mechanisms: a report of two cases

reported varies between studies; 97%, 89%, 67%, 46%, 29% to 15%. The grade and stage within these studies have not always been quoted and thresholds for positivity have differed, making comparisons difficult. In this study we observed 83% positivity in tissue sections compared with 93% positivity in bladder washings. Jiang and Buchumensky showed no correlation between CK expression and grade or stage. A recent publication has suggested the value of CK20 immunocytology. Reports in the literature suggest that CK13 is positive in well-differentiated lesions. No such association was apparent in our cases. The observation that bladder washings corresponding to tissue sections with CK13 basal staining are positive suggests that the cells shed into bladder washings are obtained from layers deeper within the epithelial layer. In summary, this study has indicated that bladder washings from TCCB patients provide cell populations that are predominantly malignant. As bladder washings from tumours with non-staining in the superficial layer had high ID scores, it can be inferred that the bladder washings contained not only superficial cells, but also cells from deeper layers.

[1]  T. Tsuzuki,et al.  ALK-1 Expression in Inflammatory Myofibroblastic Tumor of the Urinary Bladder , 2004, The American journal of surgical pathology.

[2]  E. Do,et al.  Multi-Lineage Interrogation of the Performance Characteristics of a Split-Signal Fluorescence In Situ Hybridization Probe for Anaplastic Lymphoma Kinase Gene Rearrangements A Study of 101 Cases Characterized by Immunohistomorphology on Fixed Archival Tissue , 2004 .

[3]  E. Jaffe Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[4]  Ming Zhou,et al.  Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor , 2003, Genes, chromosomes & cancer.

[5]  W. Sanger,et al.  Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases , 2002, Modern Pathology.

[6]  P. Marynen,et al.  Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor , 2002, Genes, chromosomes & cancer.

[7]  M. Ladanyi,et al.  Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. , 2001, The American journal of pathology.

[8]  S. Perkins,et al.  ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor , 2001, Modern Pathology.

[9]  M. Werner,et al.  Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas , 2000, Leukemia.

[10]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[11]  P. D. Dal Cin,et al.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.

[12]  P. Harnden,et al.  Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. , 1999, Histology and histopathology.

[13]  J. Southgate,et al.  Stromal and vascular invasion in an human in vitro bladder cancer model. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[14]  K. Pulford,et al.  Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.

[15]  R. Moll,et al.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. , 1992, The American journal of pathology.

[16]  R. Gascoyne,et al.  ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of six cases , 2003 .

[17]  Np Wang Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas , 1995 .